Eduardo Zatarain (@eduzatarain) 's Twitter Profile
Eduardo Zatarain

@eduzatarain

Clinical Cardiologist at Gregorio Marañón
Twitts are my own #CardioOnc #HF

ID: 942164907591651328

calendar_today16-12-2017 22:49:53

3,3K Tweet

891 Followers

515 Following

Circ: Heart Failure (@circhf) 's Twitter Profile Photo

Eosinophilic myocarditis in a child caused by Toxocara canis. Diagnosis via MRI & biopsy; early treatment was lifesaving. #PedsCardio #PedsID Mario O'Connor Hugo R. Martinez Dell Medical School Jason N. Johnson, MD MHS #AHAJournals ahajrnls.org/4e8jGfG

Eosinophilic myocarditis in a child caused by Toxocara canis. Diagnosis via MRI &amp; biopsy; early treatment was lifesaving. #PedsCardio #PedsID <a href="/M_OConnorC/">Mario O'Connor</a> <a href="/HugoMartinezMD/">Hugo R. Martinez</a> <a href="/DellMedSchool/">Dell Medical School</a> <a href="/Jason_N_Johnson/">Jason N. Johnson, MD MHS</a> #AHAJournals ahajrnls.org/4e8jGfG
Maria Sol Andres 🇦🇷🇬🇧 (@mariasolandres1) 's Twitter Profile Photo

#ESCardioOnco2025 has come to an end. 880 attendees, 2 days full of activities, dozens of research studies presented and tons of time to meet old friends and make new ones. The bad news: the conference has finished, the good news: this was the first of many more to come!!

#ESCardioOnco2025 has come to an end. 880 attendees, 2 days full of activities, dozens of research studies presented and tons of time to meet old friends and make new ones.  The bad news: the conference has finished, the good news: this was the first of many more to come!!
EHJOpen Editor-in-Chief (@ehjopen) 's Twitter Profile Photo

Didn't you have enough from the recent ESC Congress on #CardioOncology! The you certainly need to check the new European Society of Cardiology Journals collection for the latest updates! #OpenUpYourScience with #EHJOpen!

Michael "Mike" Albert, MD (@michaelalbertmd) 's Twitter Profile Photo

🚨 GLP-1s vs Surgery: Who Wins Long Term? - - - A new 2-year comparative study from NYU Langone just dropped—and the results are clear: 📊 Bariatric Surgery vs GLP-1s (semaglutide/tirzepatide): 🔹 25.7% total body weight loss with surgery vs 5.3% with GLP-1s (intention-to-treat)

🚨 GLP-1s vs Surgery: Who Wins Long Term?
- - -
A new 2-year comparative study from NYU Langone just dropped—and the results are clear:

📊 Bariatric Surgery vs GLP-1s (semaglutide/tirzepatide):
🔹 25.7% total body weight loss with surgery vs 5.3% with GLP-1s (intention-to-treat)
CardioHGUGM (@cardiohgugm) 's Twitter Profile Photo

Plenary talk Terrific Enrico Ammirati #ACCIS2025 New Options in Fulminant Myocarditis 📌Clinical presentation determinates acute prognosis 📌High-risk cases early refer to hub🏥 📌⚠️in #AHF, LVEF<50% or septal involvement 📌R²ABC: recognise -refer-agressive support-CSteroids

Plenary talk
Terrific  <a href="/AmmiratiEnrico/">Enrico Ammirati</a> #ACCIS2025
New Options in Fulminant Myocarditis
📌Clinical presentation determinates acute prognosis
📌High-risk cases early refer to hub🏥
📌⚠️in #AHF, LVEF&lt;50% or septal involvement 
📌R²ABC: recognise -refer-agressive support-CSteroids
European Society of Cardiology (@escardio) 's Twitter Profile Photo

The European Society of Cardiology Journals Family will have a new addition at the beginning of 2026 – the European Heart Journal - Cardio-Oncology. This exciting new publication will need an Editor-in-Chief – and we will soon be announcing the call for applications. If you want to receive updates, make

The <a href="/ESC_Journals/">European Society of Cardiology Journals</a> Family will have a new addition at the beginning of 2026 – the European Heart Journal - Cardio-Oncology. This exciting new publication will need an Editor-in-Chief – and we will soon be announcing the call for applications. 

If you want to receive updates, make
International Cardio-Oncology Society (@icosociety) 's Twitter Profile Photo

Congrats to ICOS Poland President Sebastian Szmit on his talk at the 2025 MASCC conference! Dr Szmit discussed stigma associated with #cancer care in various cultures. #cardioonc #cardiooncology

Congrats to ICOS Poland President Sebastian Szmit on his talk at the 2025 <a href="/CancerCareMASCC/">MASCC</a> conference!

Dr Szmit discussed stigma associated with #cancer care in various cultures.

#cardioonc #cardiooncology
Arya Roy (@royaryam) 's Twitter Profile Photo

🚨Proud to share our publication in JCO Oncology Practice 🧵International Medical Graduates (IMGs) are underrepresented in invited faculty roles at #ASCO Annual Meetings, despite their contributions to original research! Toni Choueiri, MD Nazli Dizman Ziad Bakouny, MD, MSc IMG Oncologists gilberto lopes

🚨Proud to share our publication in <a href="/JCOOP_ASCO/">JCO Oncology Practice</a> 
🧵International Medical Graduates (IMGs) are underrepresented in invited faculty roles at #ASCO Annual Meetings, despite their contributions to original research! <a href="/DrChoueiri/">Toni Choueiri, MD</a> <a href="/NazliDizman/">Nazli Dizman</a> <a href="/ZiadBakouny/">Ziad Bakouny, MD, MSc</a> <a href="/IMG_Oncologists/">IMG Oncologists</a> <a href="/GlopesMd/">gilberto lopes</a>
CardioHGUGM (@cardiohgugm) 's Twitter Profile Photo

Enhorabuena a nuestra compañera ElenaRodriguez por su excelente trabajo y defensa de su tesis. Estudio de la #estasisintraventricular en pacientes con #miocardiopatiadilatada. @CIBER_CV

Enhorabuena a nuestra compañera ElenaRodriguez por su excelente trabajo y defensa de su tesis. Estudio de la #estasisintraventricular en pacientes con #miocardiopatiadilatada. @CIBER_CV
Avirup Guha, MBBS, MPH, FICOS, FACC, FAHA, FESC (@avirupguha) 's Twitter Profile Photo

📢🧵Two back-to-back papers highlight a critical and overlooked issue in HR+/HER2– metastatic breast cancer (mBC): ⚠️cardiovascular comorbidities & QTc-risk meds are the norm, not exception. Here’s what we found & why it matters for oncologists + cardiologists👇Susan dent

Jennifer Liu (@jliu_mskcardonc) 's Twitter Profile Photo

Reduced echo monitoring every 6 months is safe and feasible for low risk HER2+ BC patients, per #Anthony Yu et al. A key step toward evidence-based, risk-adapted monitoring. #CardioOnc #CTRCD JACC Journals Kazuhiro Sase dineshpmcc International Cardio-Oncology Society

Reduced echo monitoring every 6 months is safe and feasible for low risk HER2+ BC patients, per #Anthony Yu et al. A key step toward evidence-based, risk-adapted monitoring. #CardioOnc #CTRCD <a href="/JACCJournals/">JACC Journals</a> <a href="/ksase/">Kazuhiro Sase</a> <a href="/dineshpmcc1/">dineshpmcc</a> <a href="/ICOSociety/">International Cardio-Oncology Society</a>
Javier Torres (@jtllergo) 's Twitter Profile Photo

⚠️ HF hospitalizations and clinical outcomes in patients undergoing tricuspid transcatheter edge-to-edge repair: EuroTR‼️ ✅ T-TEER significantly ⬇️ HFH risk, with residual TR grade ≤2 being the key predictor for reduced HFH incidence‼️ Soc Esp Cardiología SACardiología

⚠️ HF hospitalizations and clinical outcomes in patients undergoing tricuspid transcatheter edge-to-edge repair: EuroTR‼️

✅ T-TEER significantly ⬇️ HFH risk, with residual TR grade ≤2 being the key predictor for reduced HFH incidence‼️

<a href="/secardiologia/">Soc Esp Cardiología</a> <a href="/SACardiologia/">SACardiología</a>
CNIC (@cnic_cardio) 's Twitter Profile Photo

✨ The study led by the CNIC has identified imidazole propionate, a metabolite produced by gut bacteria, as a driver of atherosclerosis, the disease behind most heart attacks and strokes. nature 📄👇

Circulation Research (@circres) 's Twitter Profile Photo

Galán et al found that #cDC1s are proatherogenic via local #immunity & developed a novel #immunotherapy for #atherosclerosis based on cDC1-targeted lipid #nanoparticles. Learn more at ahajrnls.org/3GVqEZy @Sancholab @SBiomagMfb Almudena Ramiro Susana Carregal

Galán et al found that #cDC1s are proatherogenic via local #immunity &amp; developed a novel #immunotherapy for #atherosclerosis based on cDC1-targeted lipid #nanoparticles. Learn more at ahajrnls.org/3GVqEZy

@Sancholab @SBiomagMfb <a href="/aramiro_ramiro/">Almudena Ramiro</a> <a href="/CarregalSusana/">Susana  Carregal</a>
CardioOncologia SEC (@cardiooncosec) 's Twitter Profile Photo

GLOBAL CARDIO-ONCOLOGY SUMMIT #GCOS2025 🗓️31 oct - 1 nov 📍Cape Town 🇿🇦 💳 Descuento inscripción hasta 30 Ago 📣 Sesiones con expertos como Teresa Lopez Fernandez Susan dent & Dr Alexander Lyon, casos clínicos y debates interactivos Y mucho más 👇 cososa.org.za/gcos2025-globa…

GLOBAL CARDIO-ONCOLOGY SUMMIT #GCOS2025
 🗓️31 oct - 1  nov 
📍Cape Town 🇿🇦 
💳 Descuento inscripción hasta 30 Ago
📣 Sesiones con expertos como <a href="/TeresaLpezFdez1/">Teresa Lopez Fernandez</a>  <a href="/sdent_cardioonc/">Susan dent</a> &amp; Dr Alexander Lyon, casos clínicos y debates interactivos

Y mucho más 👇

cososa.org.za/gcos2025-globa…